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Abstract
We report the case of an HIV-infected patient with
vulv-ulcer as first manifestation associated with Peni-
cillium marneffei,  which  is  of  special  interest  for
healthcare workers in all fields.
casE REPoRt
a 23-year-old woman was admitted to our department
with  the  chief  complaint  of  an  1-month-history  of
painful vulv-ulcer and a two-week fever. she reported
an 1-month-history of vulv-ulcer and expanded in the
past two weeks. Initially rapid plasma reagin circle card
test  (RPR)  and  treponema  palidum  hemaglutination
assay  (tPHa)  were  detected  positively,  and  treated
with  benzylpenicillin  with  no  improvement.  Physical
examinations showed lymphadenopathy, swelling and
tenderness,  in  supraclavicular,  axillary  and  inguinal.
on both sides of the labia majora there were ulcers,
well-defined  and  slightly  swelled  up,  palpated  softly
and painly. His hemogram values at admission were a
leukocyte count = 6.3 x 103 cells/ﾵl(normal range =
4–10  x  103 cells/ﾵl)  comprising  92.4%  neutrophils
(normal  range  =  50%-70%),  hemoglobin  level  =
7.6g/dl (normal range = 11–15g/dl); Blood chemistry
data  showed  an  aspartate  aminotransferase  level  of
176u/l(normal range = 0–50u/l), an alanine amino-
transferase  level  of  91u/l  (normal  range  =
0–50u/l). RPR was negative and tPHa was positive.
Herpes simplex virus II and hepatitis virus were nega-
tive.  the  patient  was  serologically  positive  for  HIV
and her cd4
+ t lymphocyte count was 8 cells/ﾵl. au-
tologous antibody was negative. ulcer secretions and
blood culture demonstrated Penicillium marneffei posi-
tive and gram negative bacilli negative. a chest radi-
ograph showed normal. Biopsy was unavailable for pa-
tient’s  refusal.  the  patient  received  intravenous
voriconazole for 6 days of treatment (6 mg per kilo-
gram intravenously twice a day on day 1, followed by 4
mg per kilogram intravenously twice daily for 5 days),
the temperature decreased to normal and tenderness
of ulcer lightened and discharged with Itraconazole
for the patient’s requirement. the patient was still alive
and not recurrent.
dIscussIon
Penicilliosis marneffei, an opportunistic infectious dis-
ease caused the dimorphic fungus Penicilliosis marnef-
fei that grows as a mold at 25ﾰc and as a yeast at 37ﾰc
and has emerged as the third most common oppor-
tunistic  pathogen  among  HIV-positive  individuals  in
southeast asia [1]. the clinical manifestations of dis-
seminated P. marneffei infection are non-specific and
include fever, anaemia, generalized lymph  adenopathy
and hepatomegaly. cutaneous manifestations may pro-
vide  a  clue  to  the  diagnosis-typically,  umbilicated
papules with or without central necrosis (molluscum-
contagiosum-like) distributed on the upper trunk, up-
per extremities, face and scalp [2].
although no anti-fungal agents have received regu-
latory  approval  specifically  for  systemic  Penicillium
marneffei infection, response to anti-fungal therapy is
good  if  the  treatment  is  started  early,  and  ampho-
tericin B and itraconazole are generally effective [3]. 
Voriconazole is a new extended-spectrum triazole
anti-fungal agent with potent in vitro activity against a
range  of  molds,  yeasts,  and  dematiaceous  fungi  [4].
the in vitro activities of voriconazole against Penicilli-
um marneffei are superior to those of amphotericin B
and comparable with those of itraconazole; voricona-
zole minimum inhibitory concentrations (determined
using nccls and Etest methods) were in the range of
< 0.01–0.06 ﾵg/ml, and minimum fungicidal concen-
trations were 0.12–0.5 ﾵg/ml [5].
the  results  from  these  studies  suggest  that
voriconazole  is  an  effective  therapeutic  option  for
aIds patients with systemic Penicillium marneffei in-
fection. 
the case we described is of note for several rea-
sons. (1) although genital ulcer caused by Penicillium
marneffei has been described once previously [6], to
our  knowledge,  genital  ulcer  caused  by  Penicillium
marneffei in an HIV patient is extremly rare. (2) In our
patient the vulv-ulcer was initially labeled as ‘syphilis’
because the patient had positive treponemal serologic
tests (3). the ulcer seemed like chancroid，but secre-
tion culture was Penicillium marneffei positive;(4) the
mortality  rate  in  patients  with  acute  disseminated
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10) Wu##_Umbruchvorlage  04.08.11  16:04  Seite 425penicilliosis  marneffei is high if the infection is not di-
agnosed early enough and a timely and effective anti-
fungal therapy is not used.
REfEREncEs
1. supparatpinyo  K.,  Khamwan  c,  Baosoung  V,  nelson
KE, sirisanthana t. disseminated Penicillium marneffei
infection in southeast asia. lancet. 1994 Jul 9;344(8915):
110-3.
2. Vanittanakom  n,  sirisanthana  t.  Penicillium  marneffei
infection  in  patients  infected  with  human  immunodefi-
ciency virus. curr top Med Mycol. 1997 dec;8(1-2):35-
42. Review.
3. duong  ta.  Infection  due  to  Penicillium  marneffei,  an
emerging pathogen: Review of 155 reported cases. clin
Infect dis. 1996 Jul;23(1):125-30. Review. 
4. Espinel-Ingroff  a.  In  vitro  fungicidal  activities  of
voriconazole,  itraconazole,  and  amphotericin  B  against
opportunistic  moniliaceous  and  dematiaceous  fungi.  J
clin Microbiol. 2001 Mar;39(3):954-8.
5. Espinel-Ingroff a, steele-Moore l. In vitro activities of
voriconazole against the mycelial and yeast forms of Peni-
cillium  marneffei  by  different  testing  conditions.  My-
coses. 2001; 44: 17.
6. annam V, Inamadar ac, Palit a, Koppad M, Peerapur
BV,  Yelikar  BR.  genital  ulcer  caused  by  Penicillium
marneffei in an HIV-infected patient. sex transm Infect.
2007 Jun; 83(3):249-50.
Received: May 2, 2011 / Accepted: May 16, 2011
Address for correspondence: 
nanping Wu
state Key laboratory for diagnosis and treatment of Infec-
tious disease
first affiliated Hospital
school of Medicine
Zhejiang university
Hangzhou, Zhejiang 310003
china
tel. 0086-571-87236580
E-mail: flwnp@yahoo.com.cn
EuRoPEan JouRnal of MEdIcal REsEaRcH 426 september 12, 2011
10) Wu##_Umbruchvorlage  04.08.11  16:04  Seite 426